(Q37236106)

19 August 2017

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion (English)

1 reference

19 August 2017

1 reference

Juan Carlos Mesa Gutiérrez

1

1 reference

19 August 2017

Luis Arias Barquet

2

1 reference

19 August 2017

Josep Maria Caminal

3

1 reference

19 August 2017

Mitjana

4

1 reference

19 August 2017

Sergi Prades Almolda

5

1 reference

19 August 2017

Nùria Planas Domènech

6

1 reference

19 August 2017

Octavi Pujol Goita

7

1 reference

19 August 2017

Marc Rubio Caso

8

1 reference

19 August 2017

Jorge Arruga Ginebreda

9

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

19 August 2017

Clinical Ophthalmology

1 reference

19 August 2017

2

1 reference

19 August 2017

4

1 reference

19 August 2017

787-791

1 reference

Interventions for central retinal vein occlusion: an evidence-based systematic review

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Classification of central retinal vein occlusion

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Intravitreal bevacizumab (avastin) in central retinal vein occlusion

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2699794

Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion

3 September 2018

1 reference

12 December 2020

Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report

1 reference

12 December 2020

[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]

1 reference

12 December 2020

Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion

1 reference

12 December 2020

Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease

1 reference

12 December 2020

Identifiers

DOI

10.2147/OPTH.S3798

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19668432

1 reference